top of page


Our success is the result of teamwork from our dedicated staff.

We are a patient focused home infusion company specializing in intravenous immunoglobulin (IVIG), subcutaneous immune globulin (SCIG) and acute home-infusion IV therapies.


Immune globulin is made from pooled plasma collected from thousands of donors and treated to remove contaminants to ensure product safety and integrity.


Containing antibodies against a broad spectrum of bacteria and viruses, IVIG is administered intravenously and subcutaneously. It is used primarily to treat three categories of illnesses: immune deficiencies, autoimmune neuromuscular disorders and certain neurological disorders


REMICADE® (infliximab) belongs to a class of biologic medications known as TNF-blockers. REMICADE binds to TNF-alpha, blocking its action.


Excess amounts of TNF-alpha causes the immune system to attack healthy cells in the GI tract, resulting in inflammation.

Patient and Nurse

and More

Individuals who are unable to produce adequate amounts of Ig or antibodies, such as patients with CVID, Hyper-IgM Syndromes, Wiskott Aldrich Syndrome or other forms of antibody deficiency or autoimmune state may benefit from replacement therapy with Ig. 

Below are some of the disease states where immune globulin therapy could help:

• Common Variable Immune Deficiency (CVID)
• Idiopathic thrombocytopenic Purpura (ITP)
• Kawasaki Disease inflammatory vascular disorders
• Primary Immunodeficiency (PI)
• Chronic inflammatory demyelinating polyneuropathy (CIDP)
• Multiple sclerosis

What Our Patients are Saying

Marion Weiler.
"My disorder returned 5 years ago and I have been getting IVIG all that time. The disappointment of its return has been lessened by the great treatment I've had with my nurse. I've been treated with respect, care and a bit of humor which are important to have when undergoing infusions. It's great to have her in my home and I consider her a friend as well. I look forward to our "visits" and always know I'm in great hands." 

- Marion Weiler

bottom of page